I Have $4 Million -- Will My Plan to Invest for $27,000 Monthly Work?
This income is also inconsistent, and the strategy always underperforms long-term market gains.
High-yield ETFs that rely on selling options for distributable income should only make up a minor part of an income portfolio's allocation.
10 stocks we like better than JPMorgan Nasdaq Equity Premium Income ETF ›
As always, The Motley Fool cannot and does not provide personalized investing or financial advice. This information is for informational and educational purposes only and is not a substitute for professional financial advice. Always seek the guidance of a qualified financial advisor for any questions regarding your personal financial situation. If you'd like to submit your question for feedback, you can do so here.
High-yield exchange-traded funds (ETFs) aren't exactly new, including ones that generate income by selling -- or "writing" -- options on the stocks held within the fund. As the market becomes less predictable and more difficult to navigate, though, income-producing investments that generate lots of immediate cash are becoming very popular, and understandably so. Once this cash is in your proverbial pocket, it's no longer at (much) risk of unexpectedly losing value.
As is always the case with any investment, however, these particular investments come with a downside that must not only be understood but also managed.
A well-funded individual investor recently asked an entire Reddit community what it thought about a plan to invest $4 million in a trio of high-yielding ETFs, two of which regularly use the aforementioned strategy of selling call options on stocks the funds already own.
Will this actually work? What Am I missing?by u/Ddash-3 in dividends
Here's an answer highlighting some other important details that similarly minded investors may want to consider before plowing into this plan.
What does it mean to sell covered call options?
A call option is a bet that a particular security or index will be at or above a specific price by a specific point in the future. As is the case with any bet, though, you pay to make it.
Call options -- like their bearish counterpart "put" options -- are also securities in and of themselves, and are bought and sold at ever-changing prices that reflect the market's ever-changing assumptions about their value. As with most stocks, you don't actually have to buy an option first to sell it at a higher price later. You can sell or "write" an option you don't already own and collect the cash proceeds, and then buy or "cover" that trade later at what's hopefully a lower price.
In JPMorgan Chase's case, with its JPMorgan Nasdaq Equity Premium Income ETF (NASDAQ: JEPQ) and its JPMorgan Equity Premium Income ETF (NYSEMKT: JEPI), the plan isn't to buy the call options it's selling back at a later date. The goal is largely to let that option expire altogether, which effectively closes out the position with a buy price of nothing. All the initial sale proceeds become profit.
But what if the call in question gains in value before it expires? JPMorgan is "covered" in the sense that it already owns shares that it can deliver if the call options it writes are exercised against it. (A call option is also a contract to deliver shares of a particular stock, after all, if the buyer of that call so chooses.) Fund managers can also exit short-term option trades at a loss and just move on to the next one.
For both of these ETFs, this option-selling is constantly happening, generating cash flow that's dished out to investors on a monthly basis. As of the latest look, JEPQ's annualized payout yield stands at 14.5%, while JEPI's is an impressive 11.4%. Not bad. You can certainly see why this investor likes the idea of leaning into these two ETFs with his $4 million.
These funds aren't without their downsides, though.
Writing covered calls isn't a strategy that consistently beats the market in the long run. It just monetizes the market's long-term growth by converting what would have otherwise been capital gains into tangible cash. Even then, it doesn't completely keep up. As the chart below illustrates, despite its big dividend payments since its launch in mid-2022, the total return on the JPMorgan Nasdaq Equity Premium Income ETF still lags its benchmark Nasdaq-100 index.
The JPMorgan Equity Premium Income ETF's net performance has been just as disappointing compared to its benchmark in the S&P 500 since its inception in 2020.
It's also worth noting that while the annualized yields on both funds are currently sky-high, that's based on dividends that haven't exactly grown ... or even been consistent. Our investor's plan to invest $17,000 worth of excess monthly investment income into the Vanguard S&P 500 ETF (NYSEMKT: VOO) may be challenged by the sheer inconsistency of these two ETFs' dividend payments. In some months, it could be even less than the $10,000 the investor needs to live on.
Blame the strategy of selling call options on stocks you already own, mostly. It works better some times than others, and sometimes, it doesn't work at all. Covered call strategies notoriously underperform when the market is rallying the most, for instance, by bolstering the value of the call options you've already sold that you now want to lose value.
Also note that neither of these funds is particularly tax-friendly, by virtue of perpetually generating a fair amount of taxable income. In this vein, our investor didn't clarify how much of that $4 million was in an IRA, or how old they are. Some of that presumed $27,000 in monthly investment income could be subject to taxation, though, and that assumes the investor won't also be penalized for making early withdrawals from retirement accounts. This will reduce the total amount of net income the investments are generating.
So why would anyone want to own either of these two ETFs, or any like them?
Don't dismiss the value of owning an income-producing investment, even if that income can be inconsistent, or even if your net performance ultimately lags that of the overall market. Bonds underperform stocks too, but they still have their place in plenty of people's portfolios.
The inconsistent income that the JPMorgan Nasdaq Equity Premium Income ETF and the JPMorgan Equity Premium Income ETF offer doesn't make them a great option for investors who need predictable cash flow. If you've got enough accessible cash to smooth out the rough edges, however, these two funds have their place, too.
The basic premise is reasonable enough as long as you know that exchange-traded funds like the JPMorgan Nasdaq Equity Premium Income ETF and the JPMorgan Equity Premium Income ETF will ultimately underperform their benchmarks despite their strong yields. They're not growth investments. They're income investments, and they do that job nicely, even if not consistently.
In this instance, however, accepting a little less real-time cash return in exchange for far more predictable cash flow makes sense. While it will be tough to match the big yields that JEPI and JEPQ currently boast, you can get reasonably close with alternatives like preferred stocks and higher-yield "junk" bonds that would dramatically diversify this investor's holdings.
A bit more exposure to the Schwab U.S. Dividend Equity ETF (NYSEMKT: SCHD) already in the hypothetical portfolio would help, too. It's yielding just under 4% right now, which isn't much compared to JEPI and JEPQ. But it's a yield based on dividend payments that are much more consistent. And predictability means a lot when your portfolio needs to perform a minimum way right out of the gate.
This particular investor may also want to consider positioning for a little more capital appreciation that can't happen with the current plan. The investor didn't mention their age, but if they're going to live another 15 years or more, inflation and a couple of unexpected black swan events could take a sizable bite out of their future buying power. Diversifying the kinds of strategies they're using will help just as much as diversifying the kinds of stocks they're holding.
Bottom line? There are no market-beating tricks in the long run. Successful investing is still largely a game of patience won by people who know and understand all their risks and manage them accordingly with diversification.
Before you buy stock in JPMorgan Nasdaq Equity Premium Income ETF, consider this:
The Motley Fool Stock Advisor analyst team just identified what they believe are the for investors to buy now… and JPMorgan Nasdaq Equity Premium Income ETF wasn't one of them. The 10 stocks that made the cut could produce monster returns in the coming years.
Consider when Netflix made this list on December 17, 2004... if you invested $1,000 at the time of our recommendation, you'd have $713,547!* Or when Nvidia made this list on April 15, 2005... if you invested $1,000 at the time of our recommendation, you'd have $966,931!*
Now, it's worth noting Stock Advisor's total average return is 1,062% — a market-crushing outperformance compared to 177% for the S&P 500. Don't miss out on the latest top 10 list, available when you join .
See the 10 stocks »
*Stock Advisor returns as of June 23, 2025
JPMorgan Chase is an advertising partner of Motley Fool Money. James Brumley has no position in any of the stocks mentioned. The Motley Fool has positions in and recommends JPMorgan Chase and Vanguard S&P 500 ETF. The Motley Fool has a disclosure policy.
I Have $4 Million -- Will My Plan to Invest for $27,000 Monthly Work? was originally published by The Motley Fool
Hashtags

Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Yahoo
13 minutes ago
- Yahoo
Prince Harry And Meghan Are Reportedly Reducing Staff To 'Save' Money Amid Luxury Lifestyle
Prince Harry and Meghan Markle have reportedly scaled back the size of their household staff in an effort to save money. The former working royals have seen their staff numbers dwindle since they relocated to the U.S., amid reports of a strained relationship between the Duchess of Sussex and her former staff members. This report comes amid a worsening rift between Prince Harry, Meghan Markle, and the royal family as the Duke of Sussex seeks reconciliation but continues to receive the silent treatment. According to Page Six, Harry and Meghan have cut off their communications team as they seek to manage their finances more effectively. The Duke and Duchess of Sussex have seen a total of up to 25 staff members leave them since they stepped down from their royal roles and relocated to the U.S. "It's the same old story – they cycle through staff as quickly as normal people cycle through toilet paper. Milk lasts longer than their employees," a royal source said. It remains unclear whether Harry and Meghan are experiencing financial difficulties, despite their hit docu-series, "Harry & Meghan," and Meghan's Netflix show, "With Love, Meghan." The couple secured a Netflix deal reportedly worth up to $100 million, but that contract is set to expire this year. The streaming giant is reportedly now opting for "first look" deals instead of exclusive contracts, which means that Harry and Meghan could re-sign for significantly less than what their current deal is worth. The situation with their Netflix contract could prove challenging for Harry and Meghan, as their lifestyle is quite expensive. They've since lost their royal protection and now have a huge annual security bill, believed to be worth around $2 million, as well as cover their travel expenses, according to Page Six. When they moved across the pond five years ago, they paid a mouth-watering $14.65 million on their Montecito home, which is now believed to be worth around $27 million. Official documents show that they took out a $9.5 million mortgage and would pay it back with interest by 2050, indicating a $5 million deposit was made. They also have to pay a substantial annual property tax of $288,000, aside from covering the costs of their staff in communications and their personal office, as well as the Archewell Foundation, production, and employees at their California home. Harry and Meghan reportedly also have to pay for a part of their foreign tours, which have seen the Montecito-based royals visit Nigeria and Colombia. Back in June, Hello! Magazine reported that Harry and Meghan abruptly lost four members of their staff following an undisclosed number who had previously left their roles. They've lost Kyle Boulia, their L.A.-based deputy press secretary, and Charlie Gipson, who has been working as their European communications director. They also lost top Archewell executives, including Director of Communications Deesha Tank and former Head of Operations Lianne Cashin. A Vanity Fair report earlier this year suggested the royal couple is not easy to work with and that Meghan would often become cold and withdrawn if "something went poorly." Another exposé by The Hollywood Reporter claimed that "everyone's terrified of Meghan" and that she was nicknamed "Duchess Difficult" by her U.S. staff. A source said, "She belittles people, she doesn't take advice. They're both poor decision-makers, they change their minds frequently. Harry is a very, very charming person — no airs at all — but he's very much an enabler. And she's just terrible." Insiders told Page Six that the couple was so upset with the Vanity Fair story that Harry went out of his way to protect his wife by getting staff to work on a Us Weekly story featuring quotes from former staff members who expressed their love for working with the duo. Harry and Meghan may soon have more to worry about as reports suggest the duke's estranged brother, Prince William, is planning to strip them of their royal titles once he becomes Britain's next king. Reports suggest that William has not fully recovered from the way Harry and Meghan hurled disturbing accusations against the palace after they stepped down from their royal roles and the impact it had on their father, King Charles. "The king was especially stung by Harry labeling him an emotionally cold father in his scathing memoir, Spare," a courtier said, per Radar Online. "But the monarch is very concerned about his image and fears backlash from his subjects. That's why he'd never dare take away Harry's Sussex title – despite all the hurt he's caused." The insider further explained that Charles is concerned about how he'd come off if he stripped them of the title, but William doesn't care. "Behind the scenes, people are saying that the royals have quietly sanctioned the title removal – if Harry and Meghan step out of line again," the source noted. "The removal would require an Act of Parliament, but those in the know say the palace has already called several secret meetings to discuss the possibility and put an actionable plan in place."
Yahoo
20 minutes ago
- Yahoo
SoFi Stock Is Betting on Crypto Again. How Should You Play SOFI Stock Here?
SoFi Technologies (SOFI) is back in the crypto universe with an expansion of its blockchain abilities. The fintech company announced the move as shares have hit a fresh 52-week high of $18.92, powered by its impressive financial performance and business expansion. Investors are now hopeful that its return to cryptocurrency will be a catalyst for further gains. As Amazon Doubles Down on Robotaxis, Is AMZN Stock a Buy? Why Citi Thinks Micron Stock Is Headed to $150 After Earnings Beat OpenAI's Partnership With Microsoft is Good, Says CEO Sam Altman; There's 'Tension,' But Already Planning 'Next Decade Together' Stop Missing Market Moves: Get the FREE Barchart Brief – your midday dose of stock movers, trending sectors, and actionable trade ideas, delivered right to your inbox. Sign Up Now! Fellow fintech companise Robinhood (HOOD) and PayPal (PYPL) have benefitted recently from their own crypto forays, boosting the bull case for SoFi here. SoFi Technologies (SOFI) is a San Francisco-based digital financial services provider that offers a suite of banking, lending, investing, and insurance products. With more than 10.9 million members, the company operates in the U.S., Latin America, Hong Kong, and Canada. SoFi is one of the most prominent fintech companies disrupting consumer finance, and it currently has a market capitalization that exceeds $20 billion. SOFI stock has surged more 200% from the 52-week low at $6.01 to trade in the $18.50 range. With shares up nearly 21% in the year to date, it is vastly outperforming the S&P 500 Index ($SPX), which is up about 6.6% YTD as of this writing. Exponential member growth and service expansion has helped SoFi achieve this run. SoFi trades at a forward price-earnings ratio of about 64.2x and a price-sales ratio of 7.3x. While these multiples are rich relative to traditional banks, they are a function of investor hopes for high growth and high fee-based revenues. SoFi posted record results for Q1 2025 with net revenue at $772 million, a growth of 33% year-over-year, and net income at $71 million. Adjusted EBITDA grew by 46% to a record high of $210 million due to a surge in fee-based revenue, which grew 67% to an all-time high of $315 million. Following these results, management raised full-year 2025 guidance. Plus, the crypto relaunch is expected to boost SoFi's reach and further enable its goal to become a legitimate one-stop-shop for digital banking. In addition to crypto trading against Bitcoin (BTCUSD) and Ethereum (ETHUSD), SoFi will provide stablecoins, lending against crypto collateral, and staking products. SoFi Money members will also be able to access self-serve international transfers through the app in the near future, the company said, an important step toward cross-border growth. SoFi earns a 'Hold' consensus rating rating with the current average price target standing at $14.30, implying downside potential of roughly 22%. The high estimate at $20 implies a somewhat tame potential return of only 8% from here. On the date of publication, Yiannis Zourmpanos had a position in: SOFI. All information and data in this article is solely for informational purposes. This article was originally published on Sign in to access your portfolio

Associated Press
21 minutes ago
- Associated Press
SHAREHOLDER REMINDER: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of West Pharmaceutical Services
Faruqi & Faruqi, LLP Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses Exceeding $100,000 In West To Contact Him Directly To Discuss Their Options If you suffered losses exceeding $100,000 in West between February 16, 2023, and February 12, 2025 and would like to discuss your legal rights, call Faruqi & Faruqi partner Josh Wilson directly at 877-247-4292 or 212-983-9330 (Ext. 1310). [You may also click here for additional information] NEW YORK, July 06, 2025 (GLOBE NEWSWIRE) -- Faruqi & Faruqi, LLP, a leading national securities law firm, is investigating potential claims against West Pharmaceutical Services, Inc. ('West' or the 'Company') (NYSE: WST) and reminds investors of the July 7, 2025 deadline to seek the role of lead plaintiff in a federal securities class action that has been filed against the Company. Faruqi & Faruqi is a leading national securities law firm with offices in New York, Pennsylvania, California and Georgia. The firm has recovered hundreds of millions of dollars for investors since its founding in 1995. See As detailed below, the complaint alleges that the Company and its executives violated federal securities laws by making false and/or misleading statements and/or failing to disclose that: (a) despite claiming strong visibility into customer demand and attributing headwinds to temporary COVID-related product destocking, West was in fact experiencing significant and ongoing destocking across its high-margin High-Value Products portfolio; (b) West's SmartDose device, which was purportedly positioned as a high-margin growth product, was highly dilutive to the Company's profit margins due to operational inefficiencies; (c) these margin pressures created the risk of costly restructuring activities, including the Company's exit from continuous glucose monitoring contracts with long-standing customers; and (d) as a result of the foregoing, Defendants' positive statements about the Company's business, operations, and prospects were materially false and/or misleading or lacked a reasonable basis. The truth about this fraud was revealed over a series of disclosures culminating on February 13, 2025, when West issued extremely weak 2025 revenue and earnings forecasts. West attributed the disappointing guidance in part to contract manufacturing headwinds, including the loss of two major continuing glucose monitoring customers that had begun transitioning to in-house manufacturing of next-generation devices after West 'made the decision to not participate going forward as our financial thresholds cannot be achieved.' West also revealed that its SmartDose wearable injector devices would be 'margin-dilutive' in 2025 and that it would be 'taking steps to improve [its SmartDose] economics, and all options are on the table.' On this news, West's stock dropped $123.17 per share, a decline of 38 percent, to close at $199.11 on February 13, 2025. The court-appointed lead plaintiff is the investor with the largest financial interest in the relief sought by the class who is adequate and typical of class members who directs and oversees the litigation on behalf of the putative class. Any member of the putative class may move the Court to serve as lead plaintiff through counsel of their choice, or may choose to do nothing and remain an absent class member. Your ability to share in any recovery is not affected by the decision to serve as a lead plaintiff or not. Faruqi & Faruqi, LLP also encourages anyone with information regarding West's conduct to contact the firm, including whistleblowers, former employees, shareholders and others. To learn more about the West Pharmaceutical Services class action, go to or call Faruqi & Faruqi partner Josh Wilson directly at 877-247-4292 or 212-983-9330 (Ext. 1310). Follow us for updates on LinkedIn, on X, or on Facebook. Attorney Advertising. The law firm responsible for this advertisement is Faruqi & Faruqi, LLP ( ). Prior results do not guarantee or predict a similar outcome with respect to any future matter. We welcome the opportunity to discuss your particular case. All communications will be treated in a confidential manner. A photo accompanying this announcement is available at